Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
GUJINJEC
₹11.25
₹11.25
₹12.05
Data is not available
Markets Today
Historical Performance
As of 28-07-2026 17:36, Gujarat Inject (Kerala) Ltd. share price today is ₹0, with a change of ₹-11.80 (-100.00%) from the previous close of ₹11.8. The stock opened at ₹12.05 and traded between ₹11.25 and ₹12.05, with a total traded volume of 317439 shares. The company has a market capitalization of ₹167 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹14.3 and ₹1.9, respectively.
Gujarat Inject (Kerala) Ltd. valuation metrics include a P/E ratio of 55.8, and book value of ₹14.10. Profitability indicators show ROE of 15.33%. Gujarat Inject (Kerala) Ltd. has reported revenue of ₹46.35 Cr and net profit of ₹2.99 Cr.
Gujarat Inject (Kerala) Ltd. technical indicators include Day RSI at 38.8, Day MFI at 38.59, Day ADX at 37.01. Additional indicators include Commodity Channel Index (CCI) at -191.5 and Williams %R at -75.32. Momentum indicators show Day MACD at -0.08, Day MACD Signal Line at 0.24, DayATR at 0.69. Rate of Change indicators for Gujarat Inject (Kerala) Ltd. include ROC125 at 184.43 and ROC21 at -2.65.
Exponential moving averages include EMA5 at ₹11.7, EMA10 at ₹12.2, EMA12 at ₹12.3, EMA20 at ₹12.4, EMA26 at ₹12.3, EMA50 at ₹11.8, EMA100 at ₹10.2, EMA200 at ₹8. Simple moving averages include SMA5 at ₹11.7, SMA10 at ₹12.5, SMA20 at ₹12.8, SMA30 at ₹12.5, SMA50 at ₹11.9, SMA100 at ₹10.2, SMA150 at ₹8.3, SMA200 at ₹6.8.
Support levels for Gujarat Inject Kerala are placed at First Support ₹10.75, Second Support ₹10.10, Third Support ₹9.75. Resistance levels are seen at First Resistance ₹11.75, Second Resistance ₹12.10, Third Resistance ₹12.75. Gujarat Inject (Kerala) Ltd. shareholding pattern shows promoter holding at 0%, FII holding at 0%, DII holding at 0%, public holding at 100%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 12.45 | 30.70 | 1.63 | 1.58 | 2.42 |
| Operating Expense | 10.77 | 28.43 | 1.71 | 1.54 | 2.32 |
| Operating Profit | 1.69 | 2.27 | -0.09 | 0.03 | 0.10 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Tax | 0.44 | 0.63 | 0.01 | 0.02 | 0.02 |
| Net Profit | 1.25 | 1.64 | 0.04 | 0.07 | 0.07 |
₹11.25
↗ Bullish Moving Average
5
↘ Bearish Moving Average
11
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 0 | 0 | 0 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 100 | 100 | 100 | 100 | 100 | 100 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 3.62 L | 3.62 L | 100.00% |
| Week | 6.16 L | 6.16 L | 100.00% |
| 1 Month | 5.2 L | 5.2 L | 100.00% |
| 6 Month | 1.26 L | 1.26 L | 100.00% |
Companies with no Debt
High DVM Mid and Small Caps (subscription)
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Consistent high performing stocks over Five Years
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
Affordable Stocks with High ROE and Momentum
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Highest Recovery from 52 Week Low
Biggest Price Gainers from Open
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹141.25 | ₹38.37 | ₹544 | ₹180.05 | ₹284 | ₹25.27 |
| % Change | -0.14% | 0.00% | -2.81% | 0.00% | 0.00% | -0.12% |
| Revenue TTM (₹ Cr) | - | - | - | - | - | ₹1.27 |
| Net Profit TTM (₹ Cr) | - | - | - | - | - | ₹-0.25 |
| PE TTM | 66.30 | 8.90 | - | 12.50 | 39.10 | -59.80 |
| 1 Year Return | -0.22 | 36.63 | 461.56 | |||
| ROCE | - | - | 3.56 | - | - | - |
Vivimed Labs Ltd.
₹ 5.20
-1.14%
Curis Lifesciences Ltd.
₹ 112.00
+0.00%
Aptus Pharma Ltd.
₹ 258.00
+2.99%
Amanta Healthcare Ltd.
₹ 159.00
-0.63%
Anlon Healthcare Ltd.
₹ 15.74
-0.06%
Medistep Healthcare Ltd.
₹ 18.50
+0.00%
Patel Chem Specialities Ltd.
₹ 93.90
+2.96%
Asston Pharmaceuticals Ltd.
₹ 62.00
-0.72%
Influx Healthtech Ltd.
₹ 290.00
+1.75%
Medicamen Organics Ltd.
₹ 26.00
+1.96%
Amrutanjan Health Care Ltd.
₹ 510.25
-0.60%
Astonea Labs Ltd.
₹ 271.00
+0.00%
Amwill Health Care Ltd.
₹ 41.00
+2.47%
Valiant Laboratories Ltd.
₹ 60.06
-2.36%
Shelter Pharma Ltd.
₹ 26.76
-1.15%
Trident Lifeline Ltd.
₹ 264.30
+0.82%
Dipna Pharmachem Ltd.
₹ 4.28
-0.70%
Achyut Healthcare Ltd.
₹ 6.80
+0.89%
Sigachi Industries Ltd.
₹ 25.43
-1.97%
Windlas Biotech Ltd.
₹ 848.60
-1.04%
Vineet Laboratories Ltd.
₹ 39.00
+0.33%
Chandra Bhagat Pharma Ltd.
₹ 32.25
-4.02%
Solara Active Pharma Sciences Ltd.
₹ 507.95
+0.58%
By signing up I certify terms, conditions & privacy policy